These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 20196409

  • 1. Hypothalamic-pituitary dysfunction in survivors of childhood brain tumors in Prasat Neurological Institute.
    Lusawat A, Dhiravibulya K, Thammongkol S, Vanavanan S, Mahachoklertwattana P.
    J Med Assoc Thai; 2010 Jan; 93(1):38-47. PubMed ID: 20196409
    [Abstract] [Full Text] [Related]

  • 2. Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours.
    Spoudeas HA, Charmandari E, Brook CG.
    Med Pediatr Oncol; 2003 Apr; 40(4):224-9. PubMed ID: 12555249
    [Abstract] [Full Text] [Related]

  • 3. Presentation and evolution of organic central precocious puberty according to the type of CNS lesion.
    Trivin C, Couto-Silva AC, Sainte-Rose C, Chemaitilly W, Kalifa C, Doz F, Zerah M, Brauner R.
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):239-45. PubMed ID: 16886967
    [Abstract] [Full Text] [Related]

  • 4. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial.
    Laughton SJ, Merchant TE, Sklar CA, Kun LE, Fouladi M, Broniscer A, Morris EB, Sanders RP, Krasin MJ, Shelso J, Xiong Z, Wallace D, Gajjar A.
    J Clin Oncol; 2008 Mar 01; 26(7):1112-8. PubMed ID: 18309946
    [Abstract] [Full Text] [Related]

  • 5. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A, Murray RD, Teasdale GM, Shalet SM.
    Clin Endocrinol (Oxf); 2004 Apr 01; 60(4):476-83. PubMed ID: 15049963
    [Abstract] [Full Text] [Related]

  • 6. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas.
    Li GM, Sun XJ, Shao P.
    Chin Med J (Engl); 2008 Oct 20; 121(20):2077-82. PubMed ID: 19080279
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S, Supornsilchai V, Aroonparkmongkol S, Srivuthana S.
    J Med Assoc Thai; 2007 Oct 20; 90(10):2047-52. PubMed ID: 18041422
    [Abstract] [Full Text] [Related]

  • 8. The combined pituitary function test in children: an evaluation of the clinical usefulness of TRH and LHRH stimulation tests through a retrospective analysis of one hundred and twenty six cases.
    Westwood ME, Butler GE, McLellan AC, Barth JH.
    Clin Endocrinol (Oxf); 2000 Jun 20; 52(6):727-33. PubMed ID: 10848877
    [Abstract] [Full Text] [Related]

  • 9. Obesity and metabolic changes are common in young childhood brain tumor survivors.
    Pietilä S, Mäkipernaa A, Sievänen H, Koivisto AM, Wigren T, Lenko HL.
    Pediatr Blood Cancer; 2009 Jul 20; 52(7):853-9. PubMed ID: 19165891
    [Abstract] [Full Text] [Related]

  • 10. Hypothalamic-pituitary dysfunction after radiation for brain tumors.
    Constine LS, Woolf PD, Cann D, Mick G, McCormick K, Raubertas RF, Rubin P.
    N Engl J Med; 1993 Jan 14; 328(2):87-94. PubMed ID: 8416438
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone treatment in pituitary insufficiency: selected cases of children with craniopharyngioma and medulloblastoma.
    Kedzia A, Obara-Moszyńska M, Korman E, Rabska-Pietrzak B, Kopinski P, Trojan J, Goździcka-Józefiak A.
    Rocz Akad Med Bialymst; 2003 Jan 14; 48():28-33. PubMed ID: 14737937
    [Abstract] [Full Text] [Related]

  • 12. [Diagnosis and treatment of adult growth hormone deficiency (aGHD) resulting from brain injury--role of aGHD].
    Arita K, Hirano H, Tominaga A, Kurisu K.
    Brain Nerve; 2008 Dec 14; 60(12):1445-54. PubMed ID: 19110756
    [Abstract] [Full Text] [Related]

  • 13. Discrimination between growth hormone (GH) deficiency of hypothalamic or pituitary origin: an aid in selecting patients for GH-releasing hormone (RH) prolonged therapy.
    Keret R, Josefsberg Z, Kinarti H, Silbergeld A, Szoke B, Schally AV, Laron Z.
    Isr J Med Sci; 1988 Dec 14; 24(4-5):207-11. PubMed ID: 3132434
    [Abstract] [Full Text] [Related]

  • 14. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood.
    Odame I, Duckworth J, Talsma D, Beaumont L, Furlong W, Webber C, Barr R.
    Pediatr Blood Cancer; 2006 Mar 14; 46(3):357-62. PubMed ID: 16035080
    [Abstract] [Full Text] [Related]

  • 15. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K, Xhrouet-Heinrichs D, Massa G, Vandeweghe M, Bourguignon JP, De Schepper J, de Zegher F, Ernould C, Heinrichs C, Malvaux P, Craen M.
    J Pediatr Endocrinol Metab; 2001 Mar 14; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [Abstract] [Full Text] [Related]

  • 16. Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels.
    Dimopoulou I, Tsagarakis S, Kouyialis AT, Roussou P, Assithianakis G, Christoforaki M, Ilias I, Sakas DE, Thalassinos N, Roussos C.
    Crit Care Med; 2004 Feb 14; 32(2):404-8. PubMed ID: 14758155
    [Abstract] [Full Text] [Related]

  • 17. Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes.
    van Iersel L, Li Z, Srivastava DK, Brinkman TM, Bjornard KL, Wilson CL, Green DM, Merchant TE, Pui CH, Howell RM, Smith SA, Armstrong GT, Hudson MM, Robison LL, Ness KK, Gajjar A, Krull KR, Sklar CA, van Santen HM, Chemaitilly W.
    J Clin Endocrinol Metab; 2019 Dec 01; 104(12):6101-6115. PubMed ID: 31373627
    [Abstract] [Full Text] [Related]

  • 18. Cranial irradiation and growth hormone neurosecretory dysfunction: a critical appraisal.
    Darzy KH, Pezzoli SS, Thorner MO, Shalet SM.
    J Clin Endocrinol Metab; 2007 May 01; 92(5):1666-72. PubMed ID: 17284618
    [Abstract] [Full Text] [Related]

  • 19. High prevalence of pituitary dysfunction after aneurysmal subarachnoid hemorrhage: a long-term prospective study using dynamic endocrine testing.
    Kronvall E, Valdemarsson S, Säveland H, Nilsson OG.
    World Neurosurg; 2015 Apr 01; 83(4):574-82. PubMed ID: 25514615
    [Abstract] [Full Text] [Related]

  • 20. Long-Term Effect of Cranial Radiotherapy on Pituitary-Hypothalamus Area in Childhood Acute Lymphoblastic Leukemia Survivors.
    Follin C, Erfurth EM.
    Curr Treat Options Oncol; 2016 Sep 01; 17(9):50. PubMed ID: 27476159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.